Tejnaksh Healthcare Receives 'Sell' Rating from MarketsMOJO, Underperforms BSE 500 Index

Tejnaksh Healthcare, a microcap company in the hospital and healthcare services industry, has recently received a 'Sell' rating from MarketsMOJO on October 4th, 2024. This downgrade is based on the company's weak long-term fundamental strength, with a -2.60% CAGR growth in operating profits over the last 5 years.
In addition to this, the stock is currently in a mildly bearish range and has seen a deterioration in its technical trend since October 3rd, 2024, resulting in -5.26% returns. The Bollinger Band, a key technical factor, has also been bearish since October 3rd, 2024.

Tejnaksh Healthcare has also underperformed the BSE 500 index in the last 3 years, 1 year, and 3 months, with a negative return of -26.69% in the last year. However, the company did show positive results in June 2024, with a high debtors turnover ratio of 23.42 times and a PAT of Rs 0.60 crore.

Despite these positive results, the company's ROE of 7.6 and a price to book value of 2 indicate a very attractive valuation. The stock is currently trading at a discount compared to its average historical valuations, and its profits have risen by 73.4% in the past year, resulting in a low PEG ratio of 0.3.

It is worth noting that the majority shareholders of Tejnaksh Healthcare are the promoters themselves. This information, along with the recent downgrade by MarketsMOJO, may be important for investors to consider before making any decisions regarding this microcap company in the hospital and healthcare services industry.